More in Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Erythropoiesis-stimulating agents appear safe in lung cancer

NEW YORK (Reuters Health) – Lung cancer patients undergoing chemotherapy can be treated safely with erythropoiesis-stimulating agents (ESAs), according to findings published in the 24 January online issue of Lung Cancer. “The consequence of chemotherapy induced anemia (CIA) is particularly important for...

Reuters Health • The Doctor's Channel Daily Newscast

Excellent quality-of-life outcomes after proton therapy for prostate cancer

NEW YORK (Reuters Health) – Men 60 years old and younger have excellent quality-of-life outcomes after proton therapy for prostate cancer, according to findings published in the January 17th online issue of Cancer. Proton therapy is a highly conformal radiotherapy that delivers much less radiation dose to...

Reuters Health • The Doctor's Channel Daily Newscast

Stereotactic body radiotherapy effective for solitary pulmonary nodules

NEW YORK (Reuters Health) – Stereotactic body radiotherapy (SBRT) may be an effective alternative to surgery for solitary pulmonary nodules clinically diagnosed as lung cancer, researchers from Japan report in the January 31st online Lung Cancer. “We believe SBRT provides a new and safe treatment option...